Docetaxel-based therapy with or without estramustine as first-line chemotherapy for castration-resistant prostate cancer: a meta-analysis of four randomized controlled trials. [electronic resource]
Producer: 20111215Description: 1785-90 p. digitalISSN:- 1432-1335
No physical items for this record
Publication Type: Journal Article; Meta-Analysis
There are no comments on this title.
Log in to your account to post a comment.